These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7524682)

  • 1. LDL and acetyl-LDL inhibit the NK activity and are taken up by CD56+ lymphocytes.
    Juompan L; Fournié GJ; Benoist H
    Biochim Biophys Acta; 1994 Oct; 1224(1):1-10. PubMed ID: 7524682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of different lipoprotein receptors in natural killer cells and their effect on natural killer proliferative and cytotoxic activity.
    De Sanctis JB; Blanca I; Bianco NE
    Immunology; 1995 Nov; 86(3):399-407. PubMed ID: 8550077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of activation of human peripheral blood NK cells at the single cell level by Echinacea water soluble extracts: recruitment of lymphocyte-target conjugates and killer cells and activation of programming for lysis.
    Gan XH; Zhang L; Heber D; Bonavida B
    Int Immunopharmacol; 2003 Jun; 3(6):811-24. PubMed ID: 12781698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidized low-density lipoproteins affect natural killer cell activity by impairing cytoskeleton function and altering the cytokine network.
    Malorni W; Straface E; Di Genova G; Fattorossi A; Rivabene R; Camponeschi B; Masella R; Viora M
    Exp Cell Res; 1997 Nov; 236(2):436-45. PubMed ID: 9367628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
    Goodier MR; Londei M
    J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of LDL and acetylated LDL endocytosis by mononuclear cells in HIV infection.
    Juompan L; Puel J; Fournié GJ; Benoist H
    Biochim Biophys Acta; 1995 Aug; 1272(1):21-8. PubMed ID: 7545009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity.
    Maïza H; Leca G; Mansur IG; Schiavon V; Boumsell L; Bensussan A
    J Exp Med; 1993 Sep; 178(3):1121-6. PubMed ID: 7688788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition.
    Moretta A; Bottino C; Pende D; Tripodi G; Tambussi G; Viale O; Orengo A; Barbaresi M; Merli A; Ciccone E
    J Exp Med; 1990 Dec; 172(6):1589-98. PubMed ID: 2147946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct granzyme expression in human CD3- CD56+ large granular- and CD3- CD56+ small high density-lymphocytes displaying non-MHC-restricted cytolytic activity.
    Smyth MJ; Browne KA; Kinnear BF; Trapani JA; Warren HS
    J Leukoc Biol; 1995 Jan; 57(1):88-93. PubMed ID: 7530284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and phenotypic assessment of neonatal human leucocytes expressing natural killer cell-associated antigens.
    Bradstock KF; Luxford C; Grimsley PG
    Immunol Cell Biol; 1993 Dec; 71 ( Pt 6)():535-42. PubMed ID: 7508887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of adhesion and homing molecules by human decidual and peripheral blood lymphocytes in early pregnancy.
    Slukvin II; Chernyshov VP; Merkulova AA; Vodyanik MA; Kalinovsky AK
    Cell Immunol; 1994 Oct; 158(1):29-45. PubMed ID: 7522129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal enterotoxin B activates purified NK cells to secrete IFN-gamma but requires T lymphocytes to augment NK cytotoxicity.
    D'Orazio JA; Burke GW; Stein-Streilein J
    J Immunol; 1995 Feb; 154(3):1014-23. PubMed ID: 7529788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
    Shau H; Isacescu V; Ibayashi Y; Tokuda Y; Golub SH; Fahey JL; Sarna GP
    J Biol Response Mod; 1990 Feb; 9(1):71-80. PubMed ID: 2319261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
    Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
    J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins.
    Phillips JH; Hori T; Nagler A; Bhat N; Spits H; Lanier LL
    J Exp Med; 1992 Apr; 175(4):1055-66. PubMed ID: 1372642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
    Dons'koi BV; Chernyshov VP; Osypchuk DV
    J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the involvement of CD56 molecules in alloantigen-specific recognition by human natural killer cells.
    Suzuki N; Suzuki T; Engleman EG
    J Exp Med; 1991 Jun; 173(6):1451-61. PubMed ID: 1709676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow and peripheral blood natural killer cell activity in lymphomas. Its response to IL-2.
    Caldera LH; Leon-Ponte M; Acquatella G; Bianco NE; Blanca I
    Clin Exp Immunol; 1992 Apr; 88(1):143-8. PubMed ID: 1373350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.